Challener et al. TriNetX study. 32,000 patients. SGLT2i reduce need for gout visits (HR 0.94) ULT initiation (HR 0.69) and colchicine (HR 0.82). I worry about the discordant rates, ULT initiation much lower. @RheumNow #ACR24 Abstr#0848 https://t.co/VTKHMmDEKV https://t.co/C2opiDmBXx
Links:
Impact of SGLT2i Initiation on the Need for Urate-Lowering Therapy and Colchici…
https://acrabstracts.org/abstract/impact-of-sglt2i-initiation-on-the-need-for-u…
16-11-2024